Ann: Proposed issue of securities - SNT, page-16

Yeah, I'll probably wait and decide when we hear more. I mean if on the face of all things SNT were fully funded until mid-2025, but then a key part of that expected funding ($3.3m) is now disputed - i.e. Arna Pharma reneging on their previously agreed fixed payments & their contractual payment obligationsare in dispute - I'm not sure that's Gary's fault or that he is being fraudulent to shareholders (which it seems some here are indicating). I'm not saying they're wrong - I just don't think anyone has the facts or their head around the matter to adequately call that, yet.

I wonder what he might say at this afternoon's Techknow Roadshow? (I am likely to be unable to tune in).